Literature DB >> 27172946

Isolation and Culture of Human Endothelial Cells from Micro- and Macro-vessels.

Peter W Hewett1.   

Abstract

The endothelium from different vascular beds exhibits a high degree of phenotypic heterogeneity. Endothelial cells (EC) can be harvested easily from large vessels by mechanical removal or collagenase digestion. In particular, the human umbilical vein has been used due to its wide availability, and the study of ECs derived from it has undoubtedly greatly advanced our knowledge of vascular biology. However, the majority of the body's endothelium (>95 %) forms the microvasculature, and it is these cells providing the interface between the blood and tissues that play a critical role in the development of new blood vessels. This has led to the establishment of techniques for the isolation of microvascular ECs (MEC) from different tissues to provide more physiologically relevant in vitro models of angiogenesis and EC function.In this chapter the use of superparamagnetic beads (Dynabeads) coated with anti-PECAM-1 (CD31) antibodies (PECA-beads) to culture MECs from human adipose tissue is described along with the standard methods used to characterize them. Adipose tissue is an ideal source of MECs as it is composed mainly of adipocytes with a very rich microvasculature and is easy to disaggregate. Furthermore, it can be obtained in large quantities during plastic surgery procedures. Adipose obtained at reduction mammoplasty or abdominoplasty is first dissected free of the connective tissue, minced finely, and subjected to collagenase type II digestion. The adipocytes are removed by centrifugation to obtain a microvessel rich pellet, which is further disaggregated with trypsin/EDTA solution. Following filtration to remove fragments of the connective tissue, the pellet is incubated with PECA-beads and microvessel fragments/ECs and washed and harvested using a magnet. In addition, the adaptation of this basic technique for the isolation of the human lung and stomach MECs is also described along with common methods for the preparation of large vessel endothelial cells.

Entities:  

Keywords:  Adipose; Dynabeads; E-selectin; Endothelial cells; Microvascular; PECAM-1/CD31; von Willebrand Factor

Mesh:

Year:  2016        PMID: 27172946     DOI: 10.1007/978-1-4939-3628-1_4

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  6 in total

Review 1.  Induced Pluripotent Stem Cell-Derived Endothelial Cells: Overview, Current Advances, Applications, and Future Directions.

Authors:  Sae Jang; Alexandra Collin de l'Hortet; Alejandro Soto-Gutierrez
Journal:  Am J Pathol       Date:  2019-01-14       Impact factor: 4.307

2.  A comparison of CD105 and CD31 expression in tumor vessels of hepatocellular carcinoma by tissue microarray and flow cytometry.

Authors:  Hongyan Qian; Liping Yang; Wenjing Zhao; Haizhen Chen; Song He
Journal:  Exp Ther Med       Date:  2018-08-01       Impact factor: 2.447

Review 3.  Replacement in angiogenesis research: Studying mechanisms of blood vessel development by animal-free in vitro, in vivo and in silico approaches.

Authors:  Matthias W Laschke; Yuan Gu; Michael D Menger
Journal:  Front Physiol       Date:  2022-08-17       Impact factor: 4.755

4.  Isolation of Highly Purified and Viable Retinal Endothelial Cells.

Authors:  Nicholas W Chavkin; Kenneth Walsh; Karen K Hirschi
Journal:  J Vasc Res       Date:  2020-10-06       Impact factor: 1.934

Review 5.  iPSC-Derived Liver Organoids: A Journey from Drug Screening, to Disease Modeling, Arriving to Regenerative Medicine.

Authors:  Cristina Olgasi; Alessia Cucci; Antonia Follenzi
Journal:  Int J Mol Sci       Date:  2020-08-27       Impact factor: 5.923

6.  Improvement of islet transplantation by the fusion of islet cells with functional blood vessels.

Authors:  Lisa Nalbach; Leticia P Roma; Beate M Schmitt; Vivien Becker; Christina Körbel; Selina Wrublewsky; Mandy Pack; Thomas Später; Wolfgang Metzger; Maximilian M Menger; Florian S Frueh; Claudia Götz; Haopeng Lin; Joseline E Manning Fox; Patrick E MacDonald; Michael D Menger; Matthias W Laschke; Emmanuel Ampofo
Journal:  EMBO Mol Med       Date:  2020-11-02       Impact factor: 14.260

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.